Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

10.37
-0.0200-0.19%
Post-market: 10.370.00000.00%17:13 EDT
Volume:236.01K
Turnover:2.44M
Market Cap:518.51M
PE:-8.98
High:10.55
Open:10.39
Low:10.15
Close:10.39
Loading ...
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 26, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 16, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 28, 2023

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Oct 30, 2023

Major Issues Report

Form 8-K - Current report
Oct 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 15, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 11, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities